Panu J.
- Country
- Finland
- Department
- medical oncology
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Phase 1/2 Study of ODM-212 Plus Anti-Cancer Therapy in Patients With Advanced Solid Tumours: Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy
- Evaluation of ODM-212 in Patients with Advanced Solid Tumors: A Phase I, Dose-Escalation Study
Data & Insights
Has run more than one trial at 29 of 150 partner sites.
Specializations
Renal Cancer Research
This investigator specializes in treating advanced renal cell carcinoma, with particular expertise in clear cell renal cell carcinoma (ccRCC). Their research encompasses innovative therapeutic approaches combining targeted and immunological treatments.
- First-line Treatment Strategies
- Advanced Disease Management
- Treatment-resistant Cases
The investigator's work focuses on developing effective treatment sequences for patients with progressive disease.
Solid Tumor Studies
The investigator conducts pioneering research in advanced solid tumors, evaluating novel therapeutic compounds and their safety profiles. Their expertise extends to early-phase clinical investigations of experimental treatments.
- Novel Drug Development
- Safety Evaluations
- Treatment Optimization
Their work includes comprehensive assessment of new therapeutic agents in various solid tumor types.
Gastrointestinal Oncology
The investigator has significant experience in treating gastrointestinal stromal tumors (GIST), with particular focus on adjuvant therapy approaches. Their research examines extended treatment protocols to prevent disease recurrence.
- Adjuvant Treatment Strategies
- Recurrence Prevention
- Long-term Disease Management
Their studies aim to optimize treatment duration for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.